Showing 1 - 10 of 15
This paper revisits the compound options as introduced by R. Geske (2). Geske presented a theory for pricing an option on an option which he defined as a compound option. He developed a closed form expression for this kind of options. In this paper we will extend the notion of compound option to...
Persistent link: https://www.econbiz.de/10005824296
In this paper we determine the dependence of the n-fold compound option to the value of the firm V and to the variance rate 2. For practical purposes some numerical results are added, calculated with Mathematica and with a Fortran procedure for multivariate integrals.
Persistent link: https://www.econbiz.de/10005824300
Persistent link: https://www.econbiz.de/10006721618
Persistent link: https://www.econbiz.de/10006734564
The solvency II regulation for the non-life insurance business focuses on the application of the chain-ladder method in the EU. A recent memorandum of the EU also expresses its concern about the treatment of outlying data. Not only the appearance but certainly the consequences for the solvency...
Persistent link: https://www.econbiz.de/10008755288
Persistent link: https://www.econbiz.de/10008573805
Persistent link: https://www.econbiz.de/10005397423
"Our research wants to establish links and patterns over time between the constituent components of the cap rates, and between real interest and risk premium in particular. We developed a statistical model to predict and explain the risk premium asked for by investors buying properties...
Persistent link: https://www.econbiz.de/10011154266
Persistent link: https://www.econbiz.de/10005210122
The valuation of multi-staged pharmaceutical R&D can be interpreted as a chain of real options. In valuing these compound option models, a crucial problem is how to deal with the different types of risk. Previous models, such as Cassimon et al. (2004), offer a closed-form solution for the...
Persistent link: https://www.econbiz.de/10010572681